Escherichia coli ST1193: Following in the Footsteps of E. coli ST131

descriptionPublicationkeyboard_double_arrow_right Article 19 Jul 2022 English Publisher:American Society for MicrobiologyJournal:Antimicrobial Agents and Chemotherapy, volume 66 (issn: 0066-4804, eissn: 1098-6596,

Copyright policy )Funded by:CIHR | unidentified

Authors: Johann D. D. Pitout; Gisele Peirano; Liang Chen; Rebekah DeVinney; Yasufumi Matsumura;

doi: 10.1128/aac.00511-22

pmid: 35658504

pmc: PMC9295538

Escherichia coli ST1193: Following in the Footsteps of E. coli ST131

- Summary
- Subjects
- Metrics

Abstract

Escherichia coli ST1193 is an emerging global multidrug (MDR) high-risk clone and an important cause of community-onset urinary and bloodstream infections.

Related Organizations

Keywords

Drug Resistance, Multiple, Bacterial, Escherichia coli, Humans, Escherichia coli Infections, Phylogeny, beta-Lactamases, Anti-Bacterial Agents, Fluoroquinolones, Plasmids

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	97
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%